Study Overview
Study Name:
Prevention of Colorectal Cancer Through Multiomics Blood Testing (Freenome 005)
Purpose:
The goal of the Freenome 005 study is to develop a blood test for future generations that will detect advanced adenomas and colorectal cancer in its earliest, most treatable stages.. The study is sponsored by Freenome.
Eligibility:
The study will enroll approximately 40,000 participants across a range of racial, ethnic, and socioeconomic backgrounds.
Study Population: Participants aged between 45 and 85 who are eligible for CRC screening and scheduled for a standard-of-care screening colonoscopy.
Key Inclusion Criteria
45-85 years of age
Willing to undergo a standard-of-care screening colonoscopy
Able and willing to provide a blood sample
Able and willing to sign informed consent
Participation:
Participation is as simple as providing a standard blood draw, (we will arrange for this to be done by a phlebotomist in the convenience and privacy of your own home), shortly before or after your colonoscopy depending on your eligibility classification.
Compensation:
Participants will receive up to $100 for their time after completing their participation in the study.
Our Model
Participating is simple
1
2
3
4
FAQs
Frequently Asked Questions
Questions?


